RESUMO
This paper describes the application of a comprehensive strategic approach for integrating Green Infrastructure (GI) in urban planning in Mexican communities along the U.S-Mexico border as a means to mitigate the environmental, economic, and social impacts of inadequate stormwater management. Population growth and extended urban footprints in the region's cities have decreased rainfall infiltration and significantly increased runoff, carrying sediments and other pollutants into binational watersheds thus contributing to the pollution of aquatic habitats and potable water sources. As a strategy to mitigate these impacts, the Border Environment Cooperation Commission (BECC) developed a four year initiative with the long-term goal to support communities in building resiliency through the use of GI in public spaces such as parks, sidewalks, medians, and parking lots as a way to adapt to climate change, improve urban image, and strengthen native ecosystems. The Border Green Infrastructure Initiative was organized around training, strengthening municipal codes, developing pilot projects, restoring native vegetation, and the participation of residents, local government, and the private sector. The investment over the entire period was approximately USD$800,000. Outcomes were noteworthy. Approximately 900 professionals received various types of capacity building. Five cities and four Mexican border states were active participants in the program. Six pilot projects were implemented, three of which could capture a total volume of 4691â¯m3 of water in one year. In two sites the annual sediment collected was 656â¯m3. Finally, six technical tools were developed to assist communities in analysis and implementation. This approach represents a paradigm shift from the conventional management of stormwater through gray infrastructure and is intended to influence public policy at the local level, in a replicable and scalable way, resulting in more livable cities, improved water quality, and stronger binational environmental health.
Assuntos
Ecossistema , Meio Ambiente , Cidades , México , Política PúblicaRESUMO
BACKGROUND: Koala retrovirus (KoRV) is an endogenous and exogenous retrovirus of koalas that may cause lymphoma. As for many other gammaretroviruses, the KoRV genome can potentially encode an alternate form of Gag protein, glyco-gag. RESULTS: In this study, a convenient assay for assessing KoRV infectivity in vitro was employed: the use of DERSE cells (initially developed to search for infectious xenotropic murine leukemia-like viruses). Using infection of DERSE and other human cell lines (HEK293T), no evidence for expression of glyco-gag by KoRV was found, either in expression of glyco-gag protein or changes in infectivity when the putative glyco-gag reading frame was mutated. Since glyco-gag mediates resistance of Moloney murine leukemia virus to the restriction factor APOBEC3, the sensitivity of KoRV (wt or putatively mutant for glyco-gag) to restriction by murine (mA3) or human APOBEC3s was investigated. Both mA3 and hA3G potently inhibited KoRV infectivity. Interestingly, hA3G restriction was accompanied by extensive G â A hypermutation during reverse transcription while mA3 restriction was not. Glyco-gag status did not affect the results. CONCLUSIONS: These results indicate that the mechanisms of APOBEC3 restriction of KoRV by hA3G and mA3 differ (deamination dependent vs. independent) and glyco-gag does not play a role in the restriction.
Assuntos
Citidina Desaminase/metabolismo , Citosina Desaminase/metabolismo , Gammaretrovirus/fisiologia , Produtos do Gene gag/metabolismo , Phascolarctidae/virologia , Replicação Viral , Desaminases APOBEC , Sequência de Aminoácidos , Animais , Gammaretrovirus/genética , Gammaretrovirus/patogenicidade , Produtos do Gene gag/química , Produtos do Gene gag/genética , Células HEK293 , Humanos , Camundongos , Fases de Leitura Aberta , Transcrição Reversa , Alinhamento de SequênciaRESUMO
Pharmacological preconditioning limits myocardial infarct size after ischemia/reperfusion. Dexmedetomidine is an α(2)-adrenergic receptor agonist used in anesthesia that may have cardioprotective properties against ischemia/reperfusion injury. We investigate whether dexmedetomidine administration activates cardiac survival kinases and induces cardioprotection against regional ischemia/reperfusion injury. In in vivo and ex vivo models, rat hearts were subjected to 30 min of regional ischemia followed by 120 min of reperfusion with dexmedetomidine before ischemia. The α(2)-adrenergic receptor antagonist yohimbine was also given before ischemia, alone or with dexmedetomidine. Erk1/2, Akt and eNOS phosphorylations were determined before ischemia/reperfusion. Cardioprotection after regional ischemia/reperfusion was assessed from infarct size measurement and ventricular function recovery. Localization of α(2)-adrenergic receptors in cardiac tissue was also assessed. Dexmedetomidine preconditioning increased levels of phosphorylated Erk1/2, Akt and eNOS forms before ischemia/reperfusion; being significantly reversed by yohimbine in both models. Dexmedetomidine preconditioning (in vivo model) and peri-insult protection (ex vivo model) significantly reduced myocardial infarction size, improved functional recovery and yohimbine abolished dexmedetomidine-induced cardioprotection in both models. The phosphatidylinositol 3-kinase inhibitor LY-294002 reversed myocardial infarction size reduction induced by dexmedetomidine preconditioning. The three isotypes of α(2)-adrenergic receptors were detected in the whole cardiac tissue whereas only the subtypes 2A and 2C were observed in isolated rat adult cardiomyocytes. These results show that dexmedetomidine preconditioning and dexmedetomidine peri-insult administration produce cardioprotection against regional ischemia/reperfusion injury, which is mediated by the activation of pro-survival kinases after cardiac α(2)-adrenergic receptor stimulation.
Assuntos
Dexmedetomidina/farmacologia , Isquemia Miocárdica/prevenção & controle , Proteínas Quinases/metabolismo , Traumatismo por Reperfusão/prevenção & controle , Animais , Masculino , Isquemia Miocárdica/enzimologia , Ratos , Ratos Sprague-DawleyRESUMO
Retinoic acid-inducible gene I (RIG-I) receptor recognizes 5'-triphosphorylated RNA and triggers a signalling cascade that results in the induction of type-I interferon (IFN)-dependent responses. Its precise regulation represents a pivotal balance between antiviral defences and autoimmunity. To elucidate the cellular cofactors that regulate RIG-I signalling, we performed two global RNA interference analyses to identify both positive and negative regulatory nodes operating on the signalling pathway during virus infection. These factors were integrated with experimentally and computationally derived interactome data to build a RIG-I protein interaction network. Our analysis revealed diverse cellular processes, including the unfolded protein response, Wnt signalling and RNA metabolism, as critical cellular components governing innate responses to non-self RNA species. Importantly, we identified K-Homology Splicing Regulatory Protein (KHSRP) as a negative regulator of this pathway. We find that KHSRP associates with the regulatory domain of RIG-I to maintain the receptor in an inactive state and attenuate its sensing of viral RNA (vRNA). Consistent with increased RIG-I antiviral signalling in the absence of KHSRP, viral replication is reduced when KHSRP expression is knocked down both in vitro and in vivo. Taken together, these data indicate that KHSRP functions as a checkpoint regulator of the innate immune response to pathogen challenge.